Fluorescence Immunoassays

A dry fluorescence immunoassay analyzer designed for clinical diagnostic testing. This device is registered under the medical device approval number Xiang械注准20202220773. It is intended for use in laboratory settings to perform fluorescence-based immunoassays on patient samples.

A fluorescence immunoassay test that uses fluorescence technology to measure compounds including drugs, hormones, and proteins, offering a simple, rapid, and sensitive technique for in vitro diagnostics.

Diagnostic test kits utilizing fluorescence immunoassay technology for rapid detection of various health conditions. These tests are companion products to the fluorescence analyzer platform.

Fluorescence Immunoassay is an in vitro diagnostic test kit for clinical laboratory use, employing fluorescent detection technology to quantify analytes in patient samples. This method enables rapid, sensitive measurement of biomarkers across clinical chemistry and immunology applications with high specificity and reproducibility.

Fluorescence immunochromatography analyzer for rapid point-of-care testing (POCT) and clinical diagnostics. Detects biomarkers and analytes using fluorescence-based immunoassay technology for disease screening and monitoring. Integrates with chronic disease management systems for automated result processing and data management.

Fluorescence-based diagnostic assay for sensitive detection of biomarkers and pathogens in clinical samples.

Portable fluorescence immunoassay system for rapid point-of-care diagnostic testing. Enables detection and quantification of biomarkers in clinical specimens through fluorescence-based immunoassay methodology. Designed for laboratory and clinical use with portable form factor for decentralized testing applications.

The Q8 Pro is a point-of-care fluorescence immunoassay analyzer designed for rapid clinical testing in laboratory and bedside settings. It performs quantitative immunoassay measurements for cardiac markers, hormones, and infectious disease detection with automated sample processing and results reporting.

Fluorescence quantitative immunoassay platform for in vitro diagnostic testing of infectious diseases, respiratory pathogens, and gastrointestinal markers. The system enables quantitative analysis using fluorescence immunoassay technology with Class II medical device certification across multiple regulatory markets. Supports high-throughput diagnostic workflows in clinical laboratories and reference testing facilities.

Fluorescence-based diagnostic assays for medical testing and analysis. Designed for integration with optical sensor systems and imaging equipment.

Immunofluorescence-based diagnostic platform for detection and identification of specific antigens or antibodies in clinical samples. Provides fluorescence-based results for rapid point-of-care and laboratory testing.

A high-precision analyzer utilizing fluorescence immunoassay (FIA) technology for rapid immunological testing and diagnosis. The system is designed for clinical chemistry and immunofluorescence applications in point-of-care testing.